Cargando…
Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
Background: Due to the constant mutation of virus and the lack of specific therapeutic drugs, the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still poses a huge threat to the health of people, especially those with underlyin...
Autores principales: | Liu, Jiawei, Zhang, Ling, Gao, Jian, Zhang, Baochen, Liu, Xiaoli, Yang, Ninghui, Liu, Xiaotong, Liu, Xifu, Cheng, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452787/ https://www.ncbi.nlm.nih.gov/pubmed/36091808 http://dx.doi.org/10.3389/fphar.2022.961154 |
Ejemplares similares
-
Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
por: Wang, Hu, et al.
Publicado: (2022) -
Discovery of TCMs and derivatives against the main protease of SARS-CoV-2 via high throughput screening, ADMET analysis, and inhibition assay in vitro
por: Qi, Xinyu, et al.
Publicado: (2022) -
vNN Web Server for ADMET Predictions
por: Schyman, Patric, et al.
Publicado: (2017) -
Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
por: Yang, Xinbo, et al.
Publicado: (2022) -
ADMET profile and virtual screening of plant and microbial natural metabolites as SARS-CoV-2 S1 glycoprotein receptor binding domain and main protease inhibitors
por: Padhi, Srichandan, et al.
Publicado: (2021)